Brief: Advaxis Says Nasdaq Notified Co Had Not Regained Compliance With Listing Rule
June 25 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS INC - ON JUNE 22, RECEIVED NOTIFICATION FROM
NASDAQ THAT
CO HAD NOT REGAINED COMPLIANCE WITH LISTING RULE
* ADVAXIS INC - NOTIFICATION INDICATED CO’S COMMON STOCK
WOULD BE
SUBJECT TO DELISTING UNLESS CO TIMELY REQUESTS A HEARING BEFORE
NASDAQ HEARING PANEL
* ADVAXIS INC - INTENDS TO TIMELY REQUEST A HEARING BEFORE
NASDAQ
HEARING PANEL
Source text: [https://bit.ly/3gW95se]
Further company coverage: ADXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors